Pharmaceutical treatments that may prevent or delay the onset of stress fractures

Musculoskeletal Fatigue and Stress Fractures

Volumn , Issue , 2000, Pages 259-270

  Burr, David B ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 3242741646     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (73)

1. Grimston, S.K. and Zernicke, R.F., Exercise-related stress responses in bone, J. Appl. Biomech., 9, 2, 1993.
2. Clement, D.B., Tibial stress syndrome in athletes, J. Sports Med., 2, 81, 1974.
3. Matheson, G.O., Clement, D.B., McKenzie, D.C., Taunton, J.E., Lloyd-Smith, D.R., and Macintyre, J.G., Stress fractures in athletes: a study of 320 cases, Am. J. Sports Med., 15, 46, 1987.
4. Knapp, T.P. and Garrett, W.E., Jr., Stress fractures: general concepts, Clin. Sports Med., 16, 339, 1997.
5. Pope, R.P., Prevention of pelvic stress fractures in female army recruits, Mil. Med., 164, 370, 1999.
6. Andrish, J.T., Bergfeld, J.A., and Walheim, J., A prospective study on the management of shin splints, J. Bone Jt. Surg., 56A, 1697, 1974.
7. Burr, D.B., Milgrom, C., Fyhrie, D., Forwood, M., Nyska, M., Finestone, A., Hoshaw S., Saiag, E., and Simkin A., In vivo measurement of human tibial strains during vigorous activity, Bone, 18, 405, 1996.
8. Milgrom, C., Burr, D., Fyhrie, D., Forwood, M., Finestone, A., Nyska, M., Giladi, M., Liebergall, M., and Simkin, A., The effect of shoe gear on human tibial strains recorded during dynamic loading: a pilot study, Foot Ankle Int., 17, 667, 1996.
9. Burr, D.B., Bone, exercise, and stress fractures, Exerc. Sport Sci. Rev., 25, 171, 1997.
10. Fyhrie, D.P., Milgrom, C., Hoshaw, S.J., Simkin A., Car, S., Drumb, D., and Burr, D.B., Effect of fatiguing exercise on longitudinal bone strain as related to stress fracture in humans, Ann. Biomed. Eng., 26, 660, 1998.
11. Milgrom, C., Finestone, A., Levi, Y., Simkin, A., Ekenman, I., Mendelson, S., Millgram, M., Nysak, M., Benjuya, N., And Burr. D.B., Do high impact exercises produce higher tibial strains than running?, Br. J. Sports Med., 34, 195, 2000.
12. Schaffler, M.B., Radin, E.L., and Burr, D.B., Long-term fatigue behavior of compact bone at low strain magnitude and rate, Bone, 11, 321, 1990.
13. Parfitt, A.M., The morphologic basis of bone mineral measurements. Transient and steady state effects of treatment in osteoporosis, Miner. Electr. Metab., 4, 273, 1980.
14. Carter, D.R. and Hayes, W.C., The compressive behavior of bone as a two phase porous structure, J. Bone Jt. Surg., 59A, 954, 1977.
15. Rice, J.C., Cowin, S.C., and Bowman J.A., On the dependence of the elasticity and strength of cancellous bone on apparent density, J. Biomech., 21, 155, 1988.
16. Schaffler, M.B. and Burr, D.B., Stiffness of compact bone: effects of porosity and density, J. Biomech., 21, 13, 1988.
17. Martin, R.B., Mathematical model for repair of fatigue damage and stress fracture in osteonal bone, J. Orthop. Res., 13, 309, 1995.
18. Schaffler, M.B. and Boyd, R.D., Bone remodeling and microdamage accumulation in experimental stress fracture, Trans. Orthop. Res. Soc., 22, 113, 1997.
19. Burr, D.B., Milgrom, C., Boyd, R.D., Higgins, W.L., Robin, G., and Radin, E.L., Experimental stress fractures of the tibia. Biological and mechanical aetiology in rabbits, J. Bone Jt. Surg., 72B, 370, 1990.
20. Garcia, J.E., Grabhorn, L.L., and Franklin, K.J., Factors associated with stress fractures in military recruits, Mil. Med., 152, 45, 1987.
21. Kowal, D.M., Nature and causes of injuries in women resulting from an endurance training program, Am. J. Sports Med., 8, 265, 1980.
22. Sullivan, D., Warren, R.F., Pavlov, H., and Kelman, G., Stress fractures in 51 runners, Clin. Orthop. Rel. Res., 187, 188, 1984.
23. Parfitt, A.M., The cellular basis of bone remodeling: the quantum concept reexamined in light of recent advances in the cell biology of bone, Calcif. Tissue Int., 36 (Suppl. 1), S37, 1984.
24. Bennell, K.L., Malcolm, S.A., Brukner, P.D., Green, R.M., Hopper, J.L., Wark, J.D., and Ebeling, P.R., A 12-month prospective study of the relationship between stress fractures and bone turnover in athletes, Calcif. Tissue Int., 63, 80, 1998.
25. Murguia, M.J., Vailas, A., Mandelbaum, B., Norton, J., Hodgdon, J., Goforth, H., and Riedy, M., Elevated plasma hydroxyproline. A possible risk factor associated with connective tissue injuries during overuse, Am. J. Sport Med., 16, 660, 1988.
26. Heikkinen, E. and Vuori, I., Effect of physical activity on the metabolism of collagen in aged mice, Acta Physiol. Scand., 84, 543, 1972.
27. Takala, T.E.S., Vuori, J., Anttinen, H., Väänänen, K., and Myllylä, R., Prolonged exercise causes an increase in the activity of galactosylhydroxylsyl glucoyltransferase and in the concentration of type III procollagen aminopropeptide in human serum, Pfluegers Arch., 407, 500, 1986.
28. Steiniche, T., Hasling, C., Charles, P., Eriksen, E.F., Melsen, F., and Mosekilde, L., The effects of etidronate on trabecular bone remodeling in postmenopausal spinal osteoporosis: a randomized study comparing intermittent treatment and an ADFR regime, Bone, 12, 155, 1991.
29. Boyce, R.W., Paddock, C.L., Gleason, J.R., Sletsema, W.K., [sic] and Eriksen, E.F., The effects of risedronate on canine cancellous bone remodeling: three-dimensional kinetic reconstruction of the remodeling site, J. Bone Miner. Res., 10, 211, 1995.
30. Balena, R., Toolan, B.C., Shea, M., Markatos, A., Myers, E.R., Lee, S.C., Opas, E.E., Seedor, J.G., Klein, H., Frankenfield, D., Quartuccio, H., Fioravanti, C., Clair, J., Brown, E., Hayes, W.C., and Rodan, G.A., The effects of a 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomised nonhuman primates, J. Clin. Invest., 92, 2577, 1993.
31. Forwood, M.R., Burr, D.B., Takano, Y., Eastman, D.F., Smith, P.N., and Schwardt, J.D., Risedronate treatment does not increase microdamage in the canine femoral neck, Bone, 16, 643, 1995.
32. Garnero, P., Shih, W.J., Gineyts, E., Karpf, D.B., and Delmas, P.D., Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment, J. Clin. Endocrinol. Metab., 79, 1693, 1994.
33. Chesnut, C.H., McClung, M.R., Ensrud, K.E., Bell, N.H., Genant, H.K., Harris, S.T., Singer, F.R., Stock, J.L., Yood, R.A., Delmas, P.D., Kher, U., Pryor-Tillotson, S., and Santora, A.C., Alendronate treatment of the postmenopausal osteoporotic woman:effect of multiple dosages on bone mass and bone remodeling, Am. J. Med., 99, 144, 1995.
34. Flora, L., Hassing, G.S., Parfitt, A.M., and Villanueva, A.R., Comparative skeletal effects of two diphosphonates in dogs, Metab. Bone Dis. Relat. Res., 2 (Suppl.), 389, 1980.
35. Gibbs, C.J., Aaron, J.E., and Peacock, M., Osteomalacia in Paget’s disease treated with short term, high dose sodium etidronate, Br. Med. J., 292, 1127, 1986.
36. Geddes, A.D., D’Souza, S.M., Ebetino, F.H., and Ibbotson, K.J., Bisphosphonates:structure-activity relationships and therapeutic implications, Bone Miner. Res., 8, 265, 1994.
37. Yates, A.J. and Rodan, G.A., Alendronate and osteoporosis, DDT, 3, 69, 1998.
38. Kasting, G.B. and Francis, M.D., Retention of etidronate in human, dog, and rat, J. Bone Miner. Res., 7, 513, 1992.
39. Chennekatu, P.P., Guy, J., Shea, M., Bagdon, W., Kline, W.F., and Hayes, W.C., Longterm safety of the aminobisphosphonate alendronate in adult dogs. I. General safety and biomechanical properties of bone, J. Pharmacol. Exper. Ther., 276, 271, 1996.
40. Geusens, P., Nijs, J., van der Perre, G., van Audekercke, R., Lowet, G., Goovaerts, S., Barbier, A., Lacheretz, F., Remandet, B., Jiang, Y., and Dequeker, J., Longitudinal effect of tiludronate on bone mineral density, resonant frequency, and strength in monkeys, J. Bone Miner. Res., 7, 599, 1992.
41. Sato, M., Grasser, W., Endo, N., Akins, R., Simmons, H., Thompson, D.D., Golub, E., and Rodan, G.A., Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure, J. Clin. Invest., 88, 2095, 1991.
42. Rodan, G.A. and Balena R., Bisphosphonates in the treatment of metabolic bone diseases, Ann. Med., 25, 373, 1993.
43. Ferretti, J.L., Effects of bisphosphonates on bone biomechanics, in Bisphosphonate Therapy in Acute and Chronic Bone Loss, Bijvoet, A.M., Caufield, R., Fleisch, H., and Russell, R.G.G., Eds., Elsevier, Amsterdam, 1993.
44. Glatt, M., Pataki, A., Blättler, A., and Reife, R., APD long-term treatment increases bone mass and mechanical strength of femora of adult mice, Calcif. Tiss. Int., 39, A72, 1986.
45. Ferretti, J.L., Cointry, G., Capozza, R., Montuori, E., Roldán, E. and Pérez, L.A., Biomechanical effects of the full range of useful doses of (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD) on femur diaphyses and cortical bone tissue in rats, Bone Miner., 11, 101, 1990.
46. Einhorn, T., Peter, C.P., Clair, J., Rodan, G.A., and Thompson, D.D., Effect of alendronate on mechanical properties of bone in rats and dogs, J. Bone Miner. Res., 5 (Suppl. 1), S97, 1990.
47. Mashiba, T., Turner, C.H., Hirano, T., Forwood, M.R., Johnston, C.C., and Burr, D.B., The effects of suppressed bone turnover by bisphosphonates on microdamage accumulation and biomechanical properties in clinically relevant sites in beagles, Bone, (submitted).
48. Black, D.M., Cummings, S.R., Karpf, D.B., Cauley, J.A., Thompson, D.E., Nevitt, M.C., Bauer, D.C., Genant, H.K., Haskell, W.L., Marcus, R., Ott, S.M., Torner, J.C., Quandt, S.A., Reiss, T.F., and Ensrud, K.E., Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures, Lancet, 348, 1535, 1996.
49. Cummings, S.R., Black, D.M., Thompson, D.E., Applegate, W.B., Barrett-Connor, E., Musliner, T.A., Palermo, L., Prineas, R., Rubin, S.M., Scott, J.C., Vogt, T., Wallace, R., Yates, A.J., and LaCroix, A.Z., Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures, JAMA, 280, 2077, 1998.
50. Shih, M-S. and Norrdin, R.W., Effects of prostaglandins on regional remodeling changes during tibial healing in beagles. A histomorphometric study, Calcif. Tiss. Int., 39, 191, 1986.
51. Shih, M-S. and Norrdin, R.W., Effects of prostaglandin E1 on regional haversian remodeling in beagles with fractured ribs: a histomorphometric study, Bone, 8, 87, 1987.
52. Li, X.J., Jee, W.S.S., Li, Y.L., and Patterson-Buckendahl, P., Transient effects of subcutaneously administered prostaglandin E2 on cancellous and cortical bone in young adult dogs, Bone, 11, 353, 1990.
53. Jee, W.S.S., Mori, S., Li, X.J., and Chan, S., Prostaglandin E2 enhances cortical bone mass and activates intracortical bone remodeling in intact and ovariectomized female rats, Bone, 11, 253, 1990.
54. Yeh, C.-K. and Rodan, G.A., Tensile forces enhance prostaglandin E synthesis in osteoblastic cells grown on collagen ribbons, Calcif. Tissue Int., 36, S67, 1984.
55. Binderman, I., Shimshini, Z., and Somjen, D., Biochemical pathway involved in the translation of physical stimulus into biological message, Calcif. Tissue Int., 36, S82, 1984.
56. Sudmann, E. and Bang, G., Indomethacin induced inhibition of haversian remodelling in rabbits, Acta Orthop. Scand., 50, 621, 1979.
57. Keller, J., Kjærsgaard-Andersen, P., Bayer-Kristensen, I., and Melsen, F., Indomethacin and bone trauma. Effects on remodeling of rabbit bone, Acta Orthop. Scand., 61, 66, 1990.
58. Norrdin, R.W., Jee, W.S.S., and High, W.B., The role of prostaglandins in bone in vivo, Prostaglandins, Leukotrienes Essential Fatty Acids, 41, 139, 1990.
59. Keller, J., Bayer-Kristensen, I., Bak, B., Bünger, C., Kjærsgaard-Andersen, P., Lucht, U., and Melsen, F., Indomethacin and bone remodeling. Effect on cortical bone after osteotomy in rabbits, Acta Orthop. Scand., 60, 119, 1989.
60. Saffar, J.L. and Leroux, P., Role of prostaglandins in bone resorption in a synchronized remodeling sequence in the rat, Bone, 9, 141, 1988.
61. Van Tran, P., Vignery, A., and Baron, R., Cellular kinetics of the bone remodeling sequence in the rat, Anat. Rec., 202, 445, 1982.
62. Frost, H.M., The regional acceleratory phenomenon: a review, Henry Ford Hosp. Med. J., 31, 3, 1983.
63. Leroux, P. and Saffar, J.L., Dose-effect and evidence of escape of inhibition after indomethacin treatment in a synchronized model of bone resorption, Agents Actions, 38, 290, 1993.
64. Thompson, D.D. and Rodan, G.A., Indomethacin inhibition of tenotomy-induced bone resorption in rats, J. Bone Miner. Res., 3, 409, 1988.
65. Schoutens, A., Verhas, M., Dourov, N., Bergmann, P., Caulin, F., Verschaeren, A., Mone, M., and Heilporn, A., Bone loss and bone blood flow in paraplegic rats treated with calcitonin, diphosphonate, and indomethacin, Calcif. Tiss. Int., 42, 136, 1988.
66. Pead, M.J. and Lanyon, L.E., Indomethacin modulation of load-related stimulation of new bone formation in vivo, Calcif. Tiss. Int., 45, 34, 1989.
67. Aufdemorte, T.B., Fox, C., McGuff, H.S., and Holt, G.R., Flurbiprofen enhances lamellar bone formation and decreases resorption in the baboon endosseous bone wound healing model, J. Bone Miner. Res., 6 (Suppl. 1), S126, 1991.
68. Jee, W.S.S., Li, X.J., and Li, Y.L., Flurbiprofen-induced stimulation of periosteal bone formation and inhibition of bone resorption in older rats, Bone, 9, 381, 1988.
69. Li, X.J., Jee, W.S.S., and Li, Y.L., Flurbiprofen enhances growth and cancellous and cortical bone accumulation in rapidly growing long bones, Bone, 10, 35, 1989.
70. Hirano, T., Burr, D.B., Turner, C.H., Sato, M., Cain, R.L., and Hock, J.M., Anabolic effects of human biosynthetic parathyroid hormone fragment (1-34), LY333334, on remodeling and mechanical properties of cortical bone in rabbits, J. Bone Miner. Res., 14, 536, 1999.
71. Mashiba, T., Burr, D.B., Turner, C.H., Sato, M., Cain, R.L., and Hock, J.M., Effects of human PTH (1-34), LY333334, on bone mass, remodeling and mechanical properties of cortical bone during the first remodeling cycle in rabbits, Bone (submitted).
72. Burr, D.B., Hirano, T., Turner, C.H., Hotchkiss, C., Brommage, R., and Hock, J.M., Intermittently administered hPTH (1-34) treatment increases intracortical bone turnover and porosity without reducing bone strength in the humerus of ovariectomized cynomolgus monkeys, J. Bone Miner. Res., (in press).
73. Hirano, T., Burr, D.B., Cain, R.L., and Hock, J.M., Changes in geometry and cortical porosity in adult, ovary-intact rabbits after 5 months treatment with LY333334 (hPTH 1-34), Calcif. Tiss. Int., 66, 456, 2000.